In the last 3 years, Avista Capital Partners has acquired 4 companies. It has also invested in 1 other.
Avista Capital Partners’ most common sectors for investment are life science (30%) and medical products (15%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (38%) and secondary buyout (25%). In total, Avista Capital Partners has invested in 16 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2008 when it acquired ConvaTec for $4.1B.
In the last 3 years, Avista Capital Partners has exited 7 companies. The Firm’s most common exit type is trade sale (48%). Avista Capital Partners’ largest (disclosed) exit occurred in 2011 when it sold Nycomed Pharma AG for $10.8B.
Join Mergr to view Avista Capital Partners’ full profile and discover more mega-sized private equity firms just like it.
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
Join Mergr to view the latest updates and news from New York-based Avista Capital Partners.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.